BioAtla
BCAB
79 hedge funds and large institutions have $518M invested in BioAtla in 2021 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 33 increasing their positions, 15 reducing their positions, and 19 closing their positions.
1,207% more call options, than puts
Call options by funds: $2.09M | Put options by funds: $160K
120% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 15
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.07% less ownership
Funds ownership: 1.57% → 1.49% (-0.07%)
8% less funds holding
Funds holding: 86 → 79 (-7)
26% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 19
31% less capital invested
Capital invested by funds: $746M → $518M (-$228M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$24.1M |
| 2 |
Morgan Stanley
New York
|
+$10.9M |
| 3 |
BlackRock
New York
|
+$8.06M |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
+$7.62M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
+$7.56M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$22.6M |
| 2 |
SCM
Suvretta Capital Management
New York
|
-$10.4M |
| 3 |
IC
Ikarian Capital
Dallas,
Texas
|
-$5.78M |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$5.3M |
| 5 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$5.26M |
BCAB Hedge Fund Activity: Q4 2021 in Review
79 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in BioAtla (BCAB) for Q4 2021, worth a combined $518M — down 31% from $746M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of BCAB and 14 opened new positions — a net loss of 5 holders — while 15 trimmed existing stakes and 33 added.
The largest buyer was Wellington Management Group, adding an estimated $24.1M. The largest seller was Fidelity Investments, cutting an estimated $22.6M.
- 79 institutional investors held BioAtla (BCAB) as of Q4 2021, down from 86 in Q3 2021.
- Funds reported $518M of BioAtla stock for Q4 2021, down 31% quarter-over-quarter.
- 14 funds opened new BioAtla positions in Q4 2021 and 19 closed out, a net change of -5 holders.
- The largest BioAtla buyer in Q4 2021 was Wellington Management Group, an estimated $24.1M added.
- The largest BioAtla seller in Q4 2021 was Fidelity Investments, an estimated $22.6M sold.
Based on aggregated 13F filings for Q4 2021.